OnKure Therapeutics, Inc. (OKUR:NASDAQ) closed at $2.52 on October 23, 2026, down 2.33% on the day. The stock trades 53.2% below its 52-week high of $5.38 and 25.4% above its 52-week low of $2.01. Over the past year, it lost 24.1%. OnKure Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 23, 2025, OKUR closed higher on 110 days (44%). Its best day was December 5, 2025 (+16.35%) and its worst was March 27, 2026 (-13.07%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 1 time.
Reneo Pharmaceuticals Inc is a clinical stage pharmaceutical company. It is focused on the development of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate (ATP). The company is developing REN001 to modulate genes critical to metabolism and generation of ATP, which is the primary source of energy for cellular processes.
Find more stocks like OKUR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.